Liu Qingzu, Zhu Bin, Yang Huikai, Liu Chongyang, Chen Yurong, Wu Xiaoyu, Duan Wangling, Feng Luyao, Wang Binhui, Shao Liang, Gao Jianpeng, Bu Yazhong, Liu Hongjian, Mao Keya, Liu Jianheng
Department of Orthopedics, The Fourth Medical Centre of Chinese PLA General Hospital, Beijing, 100089, China.
Medical School of Chinese PLA, Beijing, 100853, China.
Bioact Mater. 2025 Aug 11;54:47-70. doi: 10.1016/j.bioactmat.2025.07.049. eCollection 2025 Dec.
The incidence of open bone defects caused by high kinetic and potential energy injuries has significantly increased. Bone grafting, typically in the form of granules, is widely recognized as the most effective treatment. However, current bone graft system is not considered ideal due to issues such as mismatched shapes and dislocation. Additionally, bone defects are frequently associated with substantial bleeding, and bone graft system often fail to effectively seal and prevent leakage, increasing the post-operative complications. In this study, based on PEG active ester (Bi-PEG-SG) and gelatin, we developed a micro-scale calf bone granules/PEG-Gelatin bioadhesive grafts delivery system with self-healing properties, which not only possesses antioxidant properties but also demonstrates injectability, shape adaptability, adhesive capabilities and high bursting pressure. This system effectively addresses the displacement issues of bone grafts and shows significant sealing and hemostatic capabilities in models of femoral artery transection hemorrhage and rabbit femoral condyle bleeding. Furthermore, the bone/bioadhesive graft delivery system serves as a sustained-release carrier for vancomycin and recombinant human bone morphogenetic protein-2, demonstrating good antibacterial performance and enhancing the osteoinductive activity and osteogenic microenvironment of calf bone granules, thereby promoting the repair of bone defects. Overall, this system offers a promising alternative for the fabrication of bone granules delivery system, demonstrating significant potential as a treatment option for open bone defects.
由高动能和势能损伤导致的开放性骨缺损发生率显著增加。骨移植,通常为颗粒形式,被广泛认为是最有效的治疗方法。然而,由于形状不匹配和移位等问题,当前的骨移植系统并不理想。此外,骨缺损常伴有大量出血,而骨移植系统往往无法有效密封并防止渗漏,增加了术后并发症。在本研究中,基于聚乙二醇活性酯(Bi-PEG-SG)和明胶,我们开发了一种具有自愈合特性的微米级小牛骨颗粒/聚乙二醇-明胶生物粘附性移植递送系统,该系统不仅具有抗氧化特性,还具备可注射性、形状适应性、粘附能力和高爆破压力。该系统有效解决了骨移植的移位问题,并在股动脉横断出血模型和兔股骨髁出血模型中显示出显著的密封和止血能力。此外,骨/生物粘附性移植递送系统作为万古霉素和重组人骨形态发生蛋白-2的缓释载体,展现出良好的抗菌性能,并增强了小牛骨颗粒的骨诱导活性和成骨微环境,从而促进骨缺损的修复。总体而言,该系统为骨颗粒递送系统的制备提供了一种有前景的替代方案,作为开放性骨缺损的治疗选择具有巨大潜力。